Immunogenicity and Safety of a Booster Dose of Live Attenuated Varicella Vaccine, and Immune Persistence of a Primary Dose for Children Aged 2 to 6 Years.

Vaccines (Basel) · 2022 · PMC9146173 · PMID 35632416

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

GMTs of 1~3 years after vaccination were 1:22.56, 1:18.49, and 1:18.45, respectively, showing a decreasing trend over time and lower than those of 30 days after basic immunization, and the differences were statistically significant ( p = 0.0002, p = 0.0003, and p = 0.0040).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.